A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer-Reference-Cited by-同舟云学术

A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer

Published:2023-09 Issue: Volume:35 Page:101718
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Osumi Hiroki,Takashima Atsuo,Ooki Akira,Yoshinari Yuri,Wakatsuki Takeru,Hirano Hidekazu,Nakayama Izuma,Okita Natsuko,Sawada Ryoichi,Ouchi Kota,Fukuda Koshiro,Fukuoka Shota,Ogura Mariko,Takahari Daisuke,Chin Keisho,Shoji Hirokazu,Kato Ken,Ishizuka Naoki,Boku Narikazu,Yamaguchi Kensei,Shinozaki Eiji

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location;Golan;Cancer,2013

2. Cost-effectiveness of RAS genetic testing strategies in patients with metastatic colorectal cancer: a systematic review;Unim;Value Health,2020

3. Cetuximab for the treatment of colorectal cancer;Jonker;New Engl. J. Med.,2007

4. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer;Van Cutsem;J. Clin. Oncol.,2007

5. Drugging the undruggable RAS: mission possible?;Cox;Nat. Rev. Drug. Discov.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study;Journal of Cancer Research and Clinical Oncology;2024-07-27

2. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy;Nature Communications;2024-07-13

3. Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer;World Journal of Gastrointestinal Oncology;2024-06-15

4. Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment;Journal of Cancer Research and Clinical Oncology;2024-05-28

5. Liquid profiling for patients with advanced cancer is ready for clinical integration;memo - Magazine of European Medical Oncology;2024-05-16